Nutritional support of the cancer patient: issues and dilemmas

被引:269
作者
Nitenberg, G [1 ]
Raynard, B [1 ]
机构
[1] Inst Gustave Roussy, Intens Care Unit, F-94805 Villejuif, France
关键词
cachexia; neoplasms; nutritional status; appetite stimulants; nutritional support; total parenteral nutrition; enteral nutrition; immunology/prevention and control; glutamine; arginine; omega-3 fatty acids;
D O I
10.1016/S1040-8428(00)00048-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malnutrition in cancer patients results from multifactorial events and is associated with an alteration of quality of life and a reduced survival. A simple nutritional assessment program and early counselling by a dietitian are essential to guide nutritional support and to alert the physician to the need for enteral (EN) or parenteral nutrition (PN). A daily intake of 20-35 kcal/kg, with a balanced contribution of glucose and lipids, and of 0.2-0.35 g nitrogen/kg is recommended both for EN and PN, with an adequate provision of electrolytes, trace elements and vitamins. EN, always preferable for patients with an intact digestive tract, and PN are both safe and effective methods of administering nutrients. The general results in clinical practice suggest no tumor growth during nutritional support. The indiscriminate use of conventional EN and PN is not indicated in well-nourished cancer patients or in patients with mild malnutrition. EN or PN is not clinically efficacious for patients treated with chemotherapy or radiotherapy, unless there are prolonged periods of GI toxicity, as in the case of bone marrow transplant patients. Severely malnourished cancer patients undergoing major visceral surgery may benefit from perioperative nutritional support, preferably via enteral access. Nutritional support in palliative care should be based on the potential risks and benefits of EN and PN, and on the patient's and family's wishes. Research is currently directed toward the impact of nutritional pharmacology on the clinical outcome of cancer patients. Glutamine-supplemented PN is probably beneficial, in bone marrow transplant patients. Immune diets are likely to reduce the rate of infectious complications and the length of hospital stay after GI surgery. Further studies are needed to determine the efficacy of such novel approaches in specific populations of cancer patients, and should also address the question of the overall cost-benefit ratio of nutritional pharmacology, and the effect of nutritional support on length and quality of life. (C) 2000 Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:137 / 168
页数:32
相关论文
共 255 条
[1]  
ABITBOL JL, 1989, CLIN NUTR, V8, pA70
[2]   REGULATION OF GUT GLUTAMINE-METABOLISM - ROLE OF HORMONES AND CYTOKINES [J].
ABUMRAD, NN ;
KIM, SJ ;
MOLINA, PE .
PROCEEDINGS OF THE NUTRITION SOCIETY, 1995, 54 (02) :525-533
[3]   Cachexia and anorexia in malignancy [J].
Albrecht, JT ;
Canada, TW .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (04) :791-&
[4]   Immunonutrition:: The role of ω-3 fatty acids [J].
Alexander, JW .
NUTRITION, 1998, 14 (7-8) :627-633
[5]   Diets and infection: Composition and consequences [J].
Alexander, JW ;
Ogle, CK ;
Nelson, JL .
WORLD JOURNAL OF SURGERY, 1998, 22 (02) :209-212
[6]  
American Gastroenterological Association Medical Position Statement, 1995, GASTROENTEROLOGY, V108, P1280, DOI DOI 10.1016/0016-5085(95)90230-9
[7]   Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation [J].
Anderson, PM ;
Ramsay, NKC ;
Shu, XO ;
Rydholm, N ;
Rogosheske, J ;
Nicklow, R ;
Weisdorf, DJ ;
Skubitz, KM .
BONE MARROW TRANSPLANTATION, 1998, 22 (04) :339-344
[8]  
Argiles JM, 1997, MED RES REV, V17, P477, DOI 10.1002/(SICI)1098-1128(199709)17:5<477::AID-MED3>3.3.CO
[9]  
2-Q
[10]   CYTOKINE REGULATION OF INTESTINAL GLUTAMINE UTILIZATION [J].
AUSTGEN, TR ;
CHEN, MK ;
DUDRICK, PS ;
COPELAND, EM ;
SOUBA, WW .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (01) :174-180